Citations

Mayo Clinic

Clear

4578 citation(s) found for "Xu, Xu Steven".

The Impact of Capitate Morphology on Scaphoid Flexion in Wrist Kinematics
Hsu, Cheng-En , Vilai, Parunyu , Wan, Rou , Zhao, Chunfeng , Moran, Steven L., Moran, Steven L.

Journal of Wrist Surgery | January 7, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/a-2772-1602 Get It

Abstract Column-type wrists, which exhibit increased scaphoid flexion during radial deviation, often experience greater loss of motion after periscaphoid arthrodesis compared with row-type wrists. Dynamic radiographic series are typically used to differentiate these kinematic patterns. In this study, we evaluate capitate morphology as a means of predicting column- or row-type carpal kinematics. This study investigated whether wrist kinematic patterns could be predicted using simple anteroposterior (AP) radiographs. We hypothesized that capitate morphology, given its close articulation with the scaphoid, influences these patterns. We analyzed 75 wrist motion radiographic series from 45 patients. Capitates were classified as either Type I (rectangular) or Type II (pentagonal) based on their shape. Wrist kinematic patterns were categorized as row- or column-type based on the degree of scaphoid length shortening during radial deviation. Our analysis revealed that a Type II capitate was a significant predictor of column-type wrists, with an odds ratio of 6.01 compared with Type I (p = 0.014). Furthermore, Type II capitates were associated with increased scaphoid flexion and reduced translation. Capitate morphology, as assessed from a plain AP radiograph, can serve as an easily accessible marker and reliable predictor of wrist motion patterns. This could potentially aid in surgical planning and patient counseling, particularly when dynamic radiographic series are not feasible. Diagnostic, Level III.
Performance of multiple multi-cancer detection tests using a large independent reference set (Alliance A212102)
Wood, Marie , Pinsky, Paul F. , Novotny, Paul J. , Leevan, Elyse , Weiss, Matthias , Edelman, Dan, Watson, Mark A. , Patriotis, Christos , Merker, Jason D. , Prorok, Philip C. , Wen, Yujia , Rubinstein, Wendy S. , Dragnev, Konstantin H. , Katki, Hormuzd A. , Chow, Selina , Kemeny, Margaret, Gautam, Umang, Reddy, Aswanth , Burak, William E. , Piantadosi, Steven , Minasian, Lori M. , Wood, Marie E , Edelman, Dan C , Watson, Mark , Dragnev, Konstantin , Skarlupka, Amanda L , Katki, Hormuzd A , Chow, Selina , Kemeny, Margaret , Piantadosi, Steven , Weiss, Matthias

JNCI: Journal of the National Cancer Institute | January 5, 2026 | Volume: 118 | Issue: 4 | Pages: 730-736

10.1093/jnci/djag001 | PMID 41499420 Get It

Abstract Background Reference sets are needed to evaluate performance of multi-cancer detection (MCD) assays. The National Cancer Institute funded the Alliance reference set study to assess MCDs for use in future trials. Methods Individuals with cancer and controls were recruited; blood specimens were collected prior to cancer treatment. A performance evaluation study was designed utilizing reference set samples. Companies (n = 6) were selected to participate based on review of performance data and ability to utilize the blood collection tube. Companies received samples from cancer types their assay was designed to detect (“targeted”), plus additional “non-targeted” and control samples. Companies reported positive/negative calls, risk scores, and tissue-of-origin (TOO) predictions. Sensitivity was computed for early (I-II) and late (III-IV) stage cases, based on positive/negative calls (SEPN) and at fixed 98% specificity (SE98). Specificity and TOO accuracy were computed. Results Five hundred and forty nine cases (encompassing 13 cancer types) and 413 controls from the reference set were included in the study. Companies assessed samples from median 6 (range 5-9) targeted cancer types and median 8 (range: 7-11) overall cancer types. Median (range) specificity was 92.3% (76.5%-98.5%). Median (range) SEPN was 32% (25%-42%) for early stage and 73% (48%-89%) for late stage; while median (range) SE98 was 19% (8%-35%) for early stage and 66% (13%-79%) for late stage. Median sensitivity for non-targeted types was 40% (early stage) and 52% (late stage). Median (range) TOO accuracy (primary predicted site) was 75% (64%-78%). Conclusions Sensitivity and specificity varied widely across assays with early-stage sensitivity substantially lower than late-stage sensitivity. Clinical Trial Registration Number ClinicalTrials.gov identifier NCT05334069.
Neck Lacerations in Ice Hockey: A Current Concepts Review From On-Ice Treatment to Prevention
Morrissette, Cole , Borchers, Charles, Margarucci, Kevin, Popkin, Michelle, Stylianos, Steven , Stuart, Michael J., Morrissette, Cole R , Stuart, Michael J. , Popkin, Charles Aaron

The American Journal of Sports Medicine | January 5, 2026 | Volume: 54 | Issue: 4 | Pages: 990-995

10.1177/03635465251380851 | PMID 41486741 Get It

Background: Neck lacerations sustained while playing ice hockey are rare but potentially fatal. Neck laceration protectors (NLPs) have been around for decades but only lately are becoming required by leagues given recent fatalities. Purpose: To outline the relevant neck anatomy at risk, describe rink-side evaluation and management techniques, review historical and contemporary NLP mandates, and conclude with evidence-based recommendations. Study Design: Narrative review; Level of evidence, 5. Methods: A review of the literature regarding neck lacerations in ice hockey was utilized for content collection. Google Scholar and PubMed were queried for peer-reviewed articles relevant to the topic. Keywords including “ice hockey,” “neck lacerations,” “neck laceration protector,” and combinations thereof were used to identify relevant literature. Results: Neck lacerations are rare but can be fatal given that they often damage zone II neurovascular structures. While numerous international leagues require mandates for NLPs, notable holdouts include the National Hockey League and the National Collegiate Athletic Association. Numerous materials and builds for NLPs are capable of withstanding penetration from a skate slash, although they possess differences in comfort and neck range of motion. Conclusion: NLPs have the capacity to prevent significant and potentially fatal laceration injuries in ice hockey. Based on the available data, implementing NLP mandates appears to be in the interest of player safety.
Purified Exosome Product Enhances Tendon-Bone Healing in a Rat Rotator Cuff Repair Model
Zhao, Gongyin, Tsukamoto, Ichiro, Yousefi, Farbod , Moran, Steven L., Sanchez-Sotelo, Joaquin L., Zhao, Chunfeng, Zhao, Gongyin , Tsukamoto, Ichiro , Sanchez-Sotelo, Joaquin, Moran, Steven L. , Behfar, Atta , Sánchez‐Sotelo, Joaquín , Zhao, Chunfeng

The American Journal of Sports Medicine | January 1, 2026 | Volume: 54 | Issue: 1 | Pages: 162-173

10.1177/03635465251395275 | PMID 41476411 Get It

Background: Tendon-bone healing after rotator cuff injury is, or remains, a clinical challenge. Purpose: To examine the role of intraoperative use of purified exosome products (PEPs) in the treatment of rotator cuff injuries and to assess the effect of PEP on supraspinatus tendon-bone healing after rotator cuff repair in a rat model. Study Design: Controlled laboratory study. Methods: This study used 120 Sprague-Dawley rats that underwent an acute supraspinatus tendon transection from the insertion, followed by repair using a single transosseous suture. They were divided into 3 groups: a control group that received only sutures, a TISSEEL group that used a commercially available fibrin sealant patch (TISSEEL) of approximately 0.5 cm 2 , and a PEP-TISSEEL group that used a similarly sized TISSEEL patch combined with PEP. Autopsies were performed at 1, 3, 6, and 8 weeks after surgery. Analyses were performed using molecular biological, biomechanical, and histological techniques. Results: At 6 weeks, the PEP-TISSEEL group achieved greater failure load (mean, 27.5 ± 5.3 N) than the control (mean, 16.4 ± 4.2 N; P = .012) and TISSEEL (mean, 23.4 ± 5.0 N; P = .041) groups, with superiority persisting at 12 weeks (27.2 ± 6.5 N vs 13.1 ± 2.6 N [ P = .002] for the control group and 21.1 ± 5.8 N [ P = .037] for the TISSEEL group). DigiGait showed earlier recovery of stride length and paw angle. Histology revealed organized collagen and reduced scarring, while molecular assays demonstrated early inflammatory modulation with subsequent upregulation of collagen type 1 or 3 and TGF-β, supporting accelerated tendon-bone healing. Conclusion: Intraoperative application of PEP-TISSEEL enhanced tendon-bone healing in a rat model by improving biomechanical strength, promoting enthesis-specific histological regeneration, and accelerating functional recovery as evidenced by gait analysis. Clinical Relevance: The intraoperative application of PEP combined with TISSEEL significantly enhances rotator cuff tendon healing by modulating early inflammation, promoting collagen synthesis, and improving biomechanical properties in a rat model. These findings suggest that PEP-based therapies could offer a promising adjunct in surgical repair, potentially reducing retear rates and improving functional outcomes in patients with rotator cuff injuries. Further clinical studies are warranted to translate these benefits into human applications.
Cutaneous Phosphorylated Alpha‐Synuclein in Lewy Body Dementia
Gibbons, Christopher H. , Levine, Todd, Bellaire, Bailey, Wang, Ningshan , Agarwal, Pinky , Aldridge, Georgina M. , Barboi, Alexandru, Claassen, Daniel O., Evidente, Virgilio G. H., Galasko, Douglas R., Gonzalez‐Duarte, Alejandra, Gil, Ramon, Gudesblatt, Mark , Khemani, Pravin , Kumar, Rajeev , Lamotte, Guillaume, Liu, Andy , Miglis, Mitchell G. , Reynolds, Adam , Sahagian, Gregory A., Saint‐Hilaire, Marie‐Helene, Schwartzbard, Julie, Yerstein, Oleg , Freeman, Roy, Claassen, Daniel O. , Liu, Andy , Claassen, Daniel , Miglis, Mitchell G , Singer, Wolfgang , Soileau, Michael J , Vernino, Steven , Freeman, Roy L. , Kaufmann, Horacio , Gibbons, Christopher , Adler, Charles H. , Evidente, Virgilio Gerald H. , Galasko, Douglas , González-Duarte, Alejandra , Isaacson, Stuart , Lamotte, Guillaume , McFarland, Nikolaus R. , Reynolds, Adam, Sahagian, Gregory , Vernino, Steven , Millar Vernetti, Patricio

Annals of Clinical and Translational Neurology | December 26, 2025 | Volume: 13 | Issue: 5 | Pages: 1041-1051

10.1002/acn3.70291 | PMID 41449577 Get It

ABSTRACT Objective To determine the test performance of cutaneous phosphorylated alpha‐synuclein (P‐SYN) in dementia with Lewy bodies (DLB), individuals with reduced Montreal Cognitive Assessment (MoCA) and healthy controls. Methods This is the first subgroup analysis of the Synuclein‐One study, a prospective, blinded study evaluating P‐SYN detection from skin biopsies in 218 subjects with a referral diagnosis of control ( N = 151) and DLB ( N = 67). All subjects completed detailed examinations, questionnaires, and had skin biopsies for detection of P‐SYN. DLB patients were included if meeting the 4th DLB consensus probable criteria. Control subjects, aged 40–99, had no history, examination findings, or symptoms suggestive of a synucleinopathy or neurodegenerative disease. An expert review panel, blinded to pathological data, determined the final diagnosis. Controls with reduced MoCA (MoCA < 26, N = 26) at screening were analyzed separately. Results After expert panel review, only 50/67 patients met consensus criteria for DLB, 26/151 controls had a reduced MoCA, and 120/151 controls had a normal MoCA. The proportions of subjects with cutaneous P‐SYN detected by skin biopsy were 96.0% (48 of 50) of the DLB group, 31% (8 of 26) of the controls with reduced MoCA, and 3.3% (4 of 120) of the controls with normal MoCA. Interpretation In this prospective, blinded, cross‐sectional study, a high proportion of subjects meeting clinical consensus criteria for DLB had P‐SYN detected in skin biopsies. Almost 1/3 of subjects with reduced MoCA testing also had P‐SYN detected. These results support a role for skin biopsy detection of P‐SYN in patients with DLB. Trial Registration NCT04700722
Association of Centrally Acting Medications, Chronic Pain, and Orthopedic Surgical History with Cognitive Impairment and Neurobehavioral Dysregulation in Former American Football Players
Puleio, Alexa, Hoti, Ina, Banks, Sarah J, Tripodis, Yorghos, Adler, Charles, Balcer, Laura J. , Bernick, Charles , Dodick, David W., Mez, Jesse, Palmisano, Joseph , Martin, Brett, Cummings, J, Reiman, EM, Shenton, Martha E., Stern, Robert A., Alosco, Michael L. , Lenio, Steven , Puleio, Alexa , Barr, William , Banks, Sarah J. , Wethe, Jennifer V. , Tripodis, Yorghos , Dodick, David W. , Cantu, Robert C. , Katz, Douglas I. , Mez, Jesse , Reiman, Eric M. , Shenton, Martha E.

Alzheimer's & Dementia | December 23, 2025 | Volume: 21 | Issue: S7 | Pages: No page available

10.1002/alz70861_108461 Get It

Abstract Background Exposure to repetitive head impacts (RHI) is associated with developing chronic traumatic encephalopathy (CTE) neuropathology. Cognitive and behavioral symptoms have been associated with CTE neuropathology, but efforts to define the specific clinical syndrome are ongoing. This study characterizes the current use of centrally acting medications (CAMs), chronic pain, and number of orthopedic surgeries in former American football players and evaluates for associations with cognitive and behavioral symptoms. Methods This study analyzed data from the DIAGNOSE CTE Research Project, which includes 120 former professional football players, 60 collegiate football players, and 56 asymptomatic men without history of RHI. Medical history was obtained by self‐report, and participants completed the Montreal Cognitive Assessment (MoCA), Brief Pain Inventory, Barratt Impulsiveness Scale‐11 (BIS‐11), BRIEF‐A Behavioral Regulation Index (BRI), Beck Depression Inventory‐II (BDI‐II), Beck Anxiety Index (BAI), and Brown‐Goodwin Lifetime History of Aggression adulthood score (BGLHA). Logistic regression assessed the association of CAMs, average pain score, and orthopedic surgeries on the cognitive impairment and neurobehavioral dysregulation components of the NINDS traumatic encephalopathy syndrome (TES) research criteria, in former American football players. Linear regression assessed the associations with MoCA and behavioral scales. Models were adjusted for age, education, race, and years of football played. Results Tables 1 and 2 describe the sample and CAM burden. More orthopedic surgeries, CAMs, and higher average pain were observed in former American football players. Number of CAMs was associated with neurobehavioral dysregulation (OR = 2.18), lower MoCA (β = ‐0.47), and higher BIS‐11 (β = 2.23), BDI‐II (β = 2.01), BRI (β = 3.71), BAI (β = 2.04), and BGLHA (β = 0.68) scores. Higher average pain was associated with neurobehavioral dysregulation (OR = 1.57) and higher BIS‐11 (β = 2.20), BDI‐II (β = 1.98), BRI (β = 2.20), BAI (β = 1.84), and BGLHA (β = 0.52) scores. No associations were observed with orthopedic surgeries. Conclusions In former American football players, the number of CAMs and higher average pain were associated with neurobehavioral dysregulation. No associations were observed with diagnosis of cognitive impairment by TES criteria, though the number of CAMs was associated with decreased MoCA.
Risk of rhabdomyolysis with concomitant use of statins and SGLT2 inhibitors: A population‐based cohort study
Awad, Kamal, Mahmoud, Ahmed K., Sheashaa, Hesham, Scalia, Isabel G. , Abdelfattah, Fatmaelzahraa , Razaghi, Mahshad , Mousa, Hana, Lester, Steven J., Arsanjani, Reza, Awad, Kamal , Sheashaa, Hesham , Pietri, Milagros Pereyra, Scalia, Isabel G , Ayoub, Chadi , Awad, Kamal , Mahmoud, Ahmed , Abbas, Mohammed Tiseer , Pereyra, Milagros , Ibrahim, Ramzi , Farina, Juan M. , Arsanjani, Reza

Journal of Internal Medicine | December 22, 2025 | Volume: 299 | Issue: 3 | Pages: 417-419

10.1111/joim.70062 | PMID 41424321 Get It

Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI)
Sater, Sam, Bifulco, Carlo B, Rodriguez-Canales, Jaime, Yeong, Joe, Akturk, Guray, Angelo, Michael, Ballesteros-Merino, Carmen, Bankhead, Peter, Basu, Subham, Blando, Jorge M, Brajkovic, Saska, Cassano, Marco, Chen, Benjamin J , Coskun, Ahmet F, Cottrell, Tricia R, Andrea, Carlos E De, Edwards, Robin H, Engle, Logan L , Fan, Rong , Feldman, Michael, Fox, Bernard A. , Galon, Jerome, Gartrell, Robyn, Gnjatic, Sacha, Green, Benjamin F, Hellebust, Anne, Hewitt, Stephen, Hollmann, Travis J, Horn, Lucas A , Howat, William J, Hoyt, Clifford C, Jensen, Shawn M, Kulasinghe, Arutha, Lassoued, Wiem , Lott, Steven, Mansfield, James, Marwitz, Sebastian , Netto, George, Page, David B. , Parra, Edwin, Rodig, Scott J, Salgado, Roberto, Schapiro, Denis, Schalper, Kurt A , Sunshine, Joel C , Surace, Michael J, Szalay, Alexander S, Thurin, Magdalena, Villasboas, Jose C, Wharton, Keith, Wistuba, Ignacio I, Yearley, Jennifer H, Yuan, Yinyin, Zaki, Geroge, Ziai, James, Gnjatic, Sacha , Netto, George J. , Egelston, Colt , Engle, Logan L , Ernstoff, Marc S. , Fan, Rong , Fox, Bernard A , Gulley, James L , Horn, Lucas A , Lassoued, Wiem , Marwitz, Sebastian , Page, David B , Rimm, David , Schalper, Kurt A , Sunshine, Joel C , Taube, Janis M , Gnjatic, Sacha , Sater, Sam, Bifulco, Carlo B, Rodriguez-Canales, Jaime, Yeong, Joe Poh-Sheng , Akturk, Guray, Angelo, Michael, Ballesteros-Merino, Carmen, Bankhead, Peter, Basu, Subham, Blando, Jorge M, Brajkovic, Saška, Cassano, Marco , Chen, Benjamin J , Coskun, Ahmet F, Cottrell, Tricia R, Andrea, Carlos E De, Edwards, Robin H, Feldman, Michael, Galon, Jérôme , Gartrell, Robyn, Green, Benjamin F, Hellebust, Anne, Hewitt, Stephen, Hollmann, Travis J, Howat, William J, Hoyt, Clifford C, Jensen, Shawn M, Kulasinghe, Arutha, Lott, Steven, Mansfield, James, Parra, Edwin, Rodig, Scott J, Salgado, Roberto, Schapiro, Denis , Surace, Michael J, Szalay, Alexander S. , Thurin, Magdalena, Villasboas, Jose C, Wharton, Keith, Wistuba, Ignacio I. , Yearley, Jennifer H, Yuan, Yinyin, Zaki, Geroge, Ziai, James

Journal for ImmunoTherapy of Cancer | December 21, 2025 | Volume: 13 | Issue: 12 | Pages: e012280

10.1136/jitc-2025-012280 | PMID 41423269 Get It

Multiplex immunofluorescence and immunohistochemistry (mIF/IHC) are increasingly employed antibody-based technologies that use tissue sparingly and facilitate the detection of co-localized or neighboring biomarkers. Specifically, these platforms enable spatial analyses of the tumor microenvironment as well as extended applications, for example, describing normal tissue anatomy, autoimmunity, infectious diseases, etc. mIF/IHC has greatly enhanced biomarker discovery efforts, and a growing number of studies suggest superiority to traditional IHC. Standardization of staining approaches, reporting of image analysis strategies and resultant data is critical for facilitating cross-study comparisons, validation, deployment, and generalization of findings. To address this challenge, The Society for Immunotherapy of Cancer (SITC) previously published two articles providing best practice guidelines for mIF/IHC staining, image analysis, and data sharing. Here, SITC convened stakeholders to develop the third article in the series, a consensus checklist for scientific reporting of mIF/IHC data to support and complement the best practice guidelines. The checklist includes critical components of mIF/IHC applications to be defined within publications such as detailed descriptions of analytical validation; image acquisition, selection, and registration methods; and cell clustering and spatial analysis strategies, amongst others. Such information will help with data reproducibility and comparison across studies towards future drug and assay development.
Evaluation of ePLAR, the echocardiographic pulmonary to left atrial ratio, in a large cohort with pulmonary hypertension
Scalia, Isabel G. , Ali, Nima Baba , Bismee, Nadera N. , Mahmoud, Ahmed K, Esfahani, Sogol Attaripour , Sheashaa, Hesham, Ibrahim, Oman H, Abdelfattah, Fatmaelzahraa , Barry, Timothy, Tamarappoo, Balaji , Scott, Robert L, Rosenthal, Julie , Lester, Steven J, Ayoub, Chadi, Arsanjani, Reza, Mahmoud, Ahmed , Scalia, Isabel G , Pietri, Milagros Pereyra, Awad, Kamal , Javadi, Niloofar , Mahmoud, Ahmed K , Tamarappoo, Balaji K, Alsidawi, Said , Ayoub, Chadi , Farina, Juan M. , Pereyra, Milagros , Abbas, Mohammed Tiseer , Awad, Kamal , Barry, Timothy , Alsidawi, Said , Scott, Robert L. , Lester, Steven J., Arsanjani, Reza

European Heart Journal Open | December 18, 2025 | Volume: 6 | Issue: 3 | Pages: No page available

10.1093/ehjopen/oeaf174 | PMID 42282056 Get It

Abstract Aims Pre-capillary pulmonary hypertension (PHTN), typically due to intrinsic pulmonary pathology, requires right heart catheterization (RHC) for diagnosis. ePLAR, the echocardiographic pulmonary to left atrial ratio [calculated: tricuspid regurgitation maximum velocity (TRVmax) divided by mitral valve E to e′ wave ratio (E/e′)], has been demonstrated as a promising non-invasive surrogate for characterization of pre-capillary PHTN. As such, this study aimed to further evaluate the diagnostic utility of ePLAR in a large cohort of patients with PHTN. Methods and results All RHCs between 2018 and 2023 across three tertiary centres were retrospectively reviewed. Patients with PHTN were characterized as pre-capillary or post-capillary (isolated or combined). Concurrent ePLAR was calculated. ROC analysis evaluated the accuracy of ePLAR in detecting pre-capillary PHTN. Overall, 2235 patients had PHTN by RHC, mean age 63.5 ± 14.7 years, 53.5% male. Of these, 43.3% had pre-capillary PHTN. ROC analysis demonstrated ePLAR to have good accuracy in detection of pre-capillary PHTN (AUC 0.760), with a cutoff of 0.20 m/s demonstrating a sensitivity and specificity of 77% and 60% respectively. This persisted on sensitivity analysis for contemporaneous investigations and for right ventricular function. Conclusion In this large cohort, ePLAR was validated as an accurate tool for identifying patients with pre-capillary PHTN. This widely available, non-invasive, and reproducible parameter can have an important role in the work up of PHTN and may guide the need for invasive testing.
Boron‐Doped Nano‐Crystalline Coated Carbon Fibers for Phasic Dopamine Sensing
Higham, Simon , Cabrera, Juan M. Rojas , Kwak, Youngjong , Hong, Lydia, Chambers, Andre , Nadarajah, Athavan, León, Sorel E. De , Jung, Young Jun , Jalilinejad, Negin , Jang, Dong Pyo , Shin, Hojin , Tong, Wei , Higham, Simon J , Blaha, Charles , Lee, Kendall, Shin, Hojin , Tong, Wei , Rojas Cabrera, Juan M , Hong, Lydia, Blaha, Charles D. , Oh, Yoonbae , Lee, Kendall , Stacey, Alastair D. , Cloherty, Shaun Liam , Ibbotson, Michael R. , Garrett, David J. , Prawer, Steven

Advanced Healthcare Materials | December 18, 2025 | Volume: 15 | Issue: 15 | Pages: No page available

10.1002/adhm.202503945 | PMID 41409014 Get It

ABSTRACT Real time, chronic electrochemical detection of neurotransmitters will provide a positive step in the treatment and understanding of neurological disease. However, current electrodes using carbon fibers (CF) fail to perform chronically. While diamond‐based coatings show promise in improving their longevity, achieving a uniform layer of such coatings on CFs is challenging, and the electrodes often lose sensitivity after coating. In this work, a complete and uniform boron‐doped nanocrystalline material grown in a diamond reactor (B‐NCD) was developed to coat CF microelectrodes for neurochemical sensing. The coating was characterized electrically, optically, mechanically, and chemically. The B‐NCD coated CF electrodes were able to detect phasic dopamine at a sensitivity comparable to the most widely used alternatives (uncoated and PEDOT:Nafion coated CFs). During biofouling testing, the B‐NCD coated CF electrodes demonstrated better stability than uncoated CFs and comparable performance to PEDOT:Nafion coated CFs. Moreover, B‐NCD exhibited no signs of degradation during consecutive FSCV applications, while uncoated and PEDOT:Nafion coated CF electrodes degraded significantly over time. Furthermore, the B‐NCD coating supported the survival and development of neurons and astrocytes in vitro, exhibited excellent adhesion and durability during mechanical bending testing, and enabled successful in vivo recording of phasic dopamine release in the rat brain. Overall, B‐NCD coated CFs present as an ideal candidate for chronic, flexible neural implantable electrodes for long‐term neurochemical monitoring.